Stocks · Health care · Biological Products, (No Diagnostic Substances)

PharmaCyte Biotech, Inc.

PMCB Clue Score43
United States Fiscal year ends April CIK 0001157075

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Jonathan Schechter
7 Jan 2026
Director
Buy
20,000
$0.84
$16.87K
Joshua Silverman
7 Jan 2026
CEO and President
Buy
40,000
$0.83
$33.32K
Jonathan Schechter
6 Jan 2026
Director
Buy
20,000
$0.79
$15.81K
Joshua Silverman
6 Jan 2026
CEO and President
Buy
30,000
$0.79
$23.67K
Jonathan Schechter
5 Jan 2026
Director
Buy
20,000
$0.78
$15.55K
Joshua Silverman
5 Jan 2026
CEO and President
Buy
30,000
$0.78
$23.49K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 4
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,268,750
History held since 30 Dec 2022